Runhao Li

Higher Degree by Research Candidate

Adelaide Medical School

Faculty of Health and Medical Sciences

Career
Publications
Contact

Appointments

Date Position Institution name

2021 - ongoing Postgraduate Research student Basil Hetzel Institute for Translational Health Research
Language Competencies

Language Competency

Chinese (Mandarin) Can read, write, speak and understand spoken

English Can read, write, speak and understand spoken
Education

Date Institution name Country Title

2022 University of Adelaide Australia PhD

2020 - 2021 University of Adelaide Australia Master

2014 - 2018 Liaoning University China Bachelor
Research Interests

Cancer Therapy Solid Tumours Tumour Immunology Cancer Biology and Clinical Oncology

Date	Position	Institution name
2021 - ongoing	Postgraduate Research student	Basil Hetzel Institute for Translational Health Research

Language	Competency
Chinese (Mandarin)	Can read, write, speak and understand spoken
English	Can read, write, speak and understand spoken

Date	Institution name	Country	Title
2022	University of Adelaide	Australia	PhD
2020 - 2021	University of Adelaide	Australia	Master
2014 - 2018	Liaoning University	China	Bachelor

Journals

Year	Citation
2024	Man Ying Li, C., Li, R., Drew, P., Price, T., Smith, E., Maddern, G. J., . . . Fenix, K. (2024). Clinical application of cytokine-induced killer (CIK) cell therapy in colorectal cancer: current strategies and future challenges. Cancer Treatment Reviews, 122, 102665-1-102665-11. DOI Scopus2 Europe PMC1
2024	Li, C. M. Y., Tomita, Y., Dhakal, B., Tin, T., Li, R., Wright, J. A., . . . Fenix, K. (2024). Generation and assessment of cytokine-induced killer cells for the treatment of colorectal cancer liver metastases. Cancer Immunology Immunotherapy, 73(1), 6-1-6-16. DOI
2024	Yeo, K., Li, R., Wu, F., Bouras, G., Mai, L. T. H., Smith, E., . . . Fenix, K. (2024). Identification of consensus head and neck cancer-associated microbiota signatures: a systematic review and meta-analysis of 16S rRNA and The Cancer Microbiome Atlas datasets. Journal of Medical Microbiology, 73(2), 001799-1-001799-18. DOI Scopus1 Europe PMC1
2024	Li, R., Liu, S., Yeo, K., Edwards, S., Li, M. Y., Santos, R., . . . Smith, E. (2024). Diagnostic and prognostic significance of circulating secreted frizzled-related protein 5 in colorectal cancer. Cancer Medicine, 13(11), 11 pages. DOI Europe PMC1
2023	Dhakal, B., Li, C. M. Y., Ramezanpour, M., Houtak, G., Li, R., Bouras, G., . . . Fenix, K. (2023). Proteomic characterisation of perhexiline treatment on THP-1 M1 macrophage differentiation. Frontiers in Immunology, 14, 13 pages. DOI Scopus3 WoS1 Europe PMC3
2023	Li, C. M. Y., Tomita, Y., Dhakal, B., Li, R., Li, J., Drew, P., . . . Fenix, K. A. (2023). Use of cytokine-induced killer cell therapy in patients with colorectal cancer: a systematic review and meta-analysis. Journal for ImmunoTherapy of Cancer, 11(4), e006764-1-e006764-17. DOI Scopus6 WoS4 Europe PMC6
2022	Dhakal, B., Li, C. M. Y., Li, R., Yeo, K., Wright, J. A., Gieniec, K. A., . . . Fenix, K. (2022). The Antianginal Drug Perhexiline Displays Cytotoxicity against Colorectal Cancer Cells In Vitro: A Potential for Drug Repurposing. Cancers, 14(4), 16 pages. DOI Scopus10 WoS7 Europe PMC9

Preprint

Year	Citation
2024	Yeo, K., Wu, F., Li, R., Smith, E., Wormald, P. -J., Valentine, R., . . . Fenix, K. (2024). Is Short-Read 16S rRNA Sequencing of Oral Microbiome Sampling a Suitable Diagnostic Tool for Head and Neck Cancer?. DOI
2024	Li, R., Liu, S., Yeo, K., Edwards, S., Li, M. Y., Santos, R., . . . Smith, E. (2024). Circulating SFRP5 levels are elevated in colorectal cancer and correlate with overall survival in stage II-III disease. DOI

Email: runhao.li@adelaide.edu.au

Runhao Li

Appointments

Language Competencies

Education

Research Interests

Journals

Preprint

Connect With Me

External Profiles